Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$2.1 - $3.36 $766,500 - $1.23 Million
-365,000 Reduced 76.84%
110,000 $254,000
Q1 2023

May 10, 2023

BUY
$2.13 - $3.6 $479,250 - $810,000
225,000 Added 90.0%
475,000 $1.21 Million
Q4 2022

Feb 10, 2023

SELL
$2.05 - $3.47 $102,499 - $173,500
-50,000 Reduced 16.67%
250,000 $627,000
Q3 2022

Nov 14, 2022

SELL
$0.63 - $5.47 $31,500 - $273,500
-50,000 Reduced 14.29%
300,000 $870,000
Q2 2022

Aug 16, 2022

BUY
$4.27 - $8.26 $234,849 - $454,300
55,000 Added 18.64%
350,000 $1.58 Million
Q1 2022

May 11, 2022

BUY
$7.07 - $11.62 $1.03 Million - $1.68 Million
145,000 Added 96.67%
295,000 $2.25 Million
Q3 2021

Nov 12, 2021

BUY
$9.94 - $12.77 $1.49 Million - $1.92 Million
150,000 New
150,000 $1.86 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Tamarack Advisers, LP Portfolio

Follow Tamarack Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tamarack Advisers, LP with notifications on news.